444 related articles for article (PubMed ID: 26970273)
1. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.
Pyne S; Adams DR; Pyne NJ
Prog Lipid Res; 2016 Apr; 62():93-106. PubMed ID: 26970273
[TBL] [Abstract][Full Text] [Related]
2. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease.
Pyne S; Lee SC; Long J; Pyne NJ
Cell Signal; 2009 Jan; 21(1):14-21. PubMed ID: 18768158
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
4. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate and cancer.
Pyne NJ; El Buri A; Adams DR; Pyne S
Adv Biol Regul; 2018 May; 68():97-106. PubMed ID: 28942351
[TBL] [Abstract][Full Text] [Related]
6. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate signalling in cancer.
Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
[TBL] [Abstract][Full Text] [Related]
8. An Improved Isoform-Selective Assay for Sphingosine Kinase 1 Activity.
Pitman MR; Davies LT; Pitson SM
Methods Mol Biol; 2018; 1697():9-20. PubMed ID: 28540558
[TBL] [Abstract][Full Text] [Related]
9. Isoform-selective assays for sphingosine kinase activity.
Pitman MR; Pham DH; Pitson SM
Methods Mol Biol; 2012; 874():21-31. PubMed ID: 22528436
[TBL] [Abstract][Full Text] [Related]
10. Involvement of sphingosine kinase/sphingosine 1-phosphate metabolic pathway in spondyloarthritis.
Bougault C; El Jamal A; Briolay A; Mebarek S; Boutet MA; Garraud T; Le Goff B; Blanchard F; Magne D; Brizuela L
Bone; 2017 Oct; 103():150-158. PubMed ID: 28684192
[TBL] [Abstract][Full Text] [Related]
11. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase inhibitors: A patent review.
Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
[TBL] [Abstract][Full Text] [Related]
13. New perspectives on the role of sphingosine 1-phosphate in cancer.
Pyne S; Pyne NJ
Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
[TBL] [Abstract][Full Text] [Related]
14. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
15. Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P
Alganga H; Almabrouk TAM; Katwan OJ; Daly CJ; Pyne S; Pyne NJ; Kennedy S
J Pharmacol Exp Ther; 2019 Oct; 371(1):63-74. PubMed ID: 31371480
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine Kinases: Emerging Structure-Function Insights.
Adams DR; Pyne S; Pyne NJ
Trends Biochem Sci; 2016 May; 41(5):395-409. PubMed ID: 27021309
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and immune regulation: trafficking and beyond.
Chi H
Trends Pharmacol Sci; 2011 Jan; 32(1):16-24. PubMed ID: 21159389
[TBL] [Abstract][Full Text] [Related]
18. The outs and the ins of sphingosine-1-phosphate in immunity.
Spiegel S; Milstien S
Nat Rev Immunol; 2011 Jun; 11(6):403-15. PubMed ID: 21546914
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
20. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha.
Pettus BJ; Bielawski J; Porcelli AM; Reames DL; Johnson KR; Morrow J; Chalfant CE; Obeid LM; Hannun YA
FASEB J; 2003 Aug; 17(11):1411-21. PubMed ID: 12890694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]